申请人:PharmAkea, Inc.
公开号:US20180186755A1
公开(公告)日:2018-07-05
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.